The diagnosed prevalent cases of Crohn’s disease (CD) in the eight major markets (*8MM) are projected to increase from 1.63 million in 2022 to 1.69 million in 2032, equating to an annual growth rate (AGR) of 0.42%, forecasts GlobalData, a leading data and analytics company.

Crohn’s disease is a type of inflammatory bowel disease (IBD) characterized by chronic inflammation of the gastrointestinal tract, which can lead to abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition. It most commonly affects the end of the small intestine (the ileum) where it joins the beginning of the colon. Inflammation caused by Crohn’s disease can involve different areas of the digestive tract in different people, most commonly the small intestine. This inflammation often spreads into the deeper layers of the bowel.

GlobalData’s latest report, “Crohn’s Disease (CD) – Epidemiology Forecast to 2032,” reveals that in 2032, the US is predicted to have the highest number of diagnosed prevalent cases of ulcerative colitis in the 8MM at 0.76 million, whereas Japan, with nearly 45 thousand cases, will have the lowest number.

Bharti Prabhakar, MPH, Associate Project Manager at GlobalData, comments: “Men and women can both be affected, and the disease can occur at any age, but CD is more prevalent among women and in the young age population. Diet and stress may aggravate CD, but do not cause the disease.”

Adults ages 18-59 years accounted for more than 68% of the diagnosed prevalent cases of CD in the 8MM while those ages 80 years and above accounted for less than 4% of the cases. This is apparent from GlobalData estimates for sex-specific diagnosed prevalent cases.

Prabhakar concludes: “Crohn’s disease can be both painful and debilitating, and sometimes may lead to life-threatening complications. Inflammation in CD can result in severe scarring and narrowing of parts of the bowel. There is no known cure for Crohn’s disease, but therapies can greatly reduce its signs and symptoms and even bring about long-term remission and healing of inflammation. With treatment, many people with Crohn’s disease can function well.”

*8MM: The US, 5EU (France, Germany, Italy, Spain, the UK), Japan, and Canada